We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Consider All Ad Content When Reviewing Risk Information
FDA to Consider All Ad Content When Reviewing Risk Information
May 29, 2009
Devicemakers should focus on the overall impression their advertising conveys to healthcare professionals and consumers to determine whether the risk information in each promotional piece complies with the law and FDA regulations, according to a draft guidance.